Pharma

Your Article Summary

See Latest Articles

Acanya? gel, a new treatment for moderate to severe acne, launched by coria laboratories
Valeant Pharmaceuticals International, 03/09/09

Coria Laboratories, the newly expanded dermatology division of Valeant Pharmaceuticals International, announced the commercial launch of Acanya Gel indicated for the once-daily treatment of acne vulgaris in patients 12 years and older. Evaluated in clinical studies enrolling over 3,200 subjects with moderate to severe acne vulgaris, Acanya Gel is the only fixed combination antibiotic and benzoyl peroxide medication FDA-approved for the once-daily treatment of both non-inflammatory and inflammatory lesions of acne.

Today in Drug/Product Approvals...keeping you current

Receive free subspecialty "5-minute updates" via email

Eslicarbazepine: A novel antiepileptic agent designed for improved efficacy and safety
Formulary , 12/16/09

Human genome sciences announces submission of marketing authorization application to emea for joulferon
Human Genome Sciences, 12/16/09

Mylan Receives Approval for Generic Version of Antiepileptic Keppra 1000 mg
Mylan, 12/15/09

 See all of Drug/Product Approvals